Accepted for Publication: March 12, 2014.
Published Online: May 5, 2014. doi:10.1001/jamaneurol.2014.689.
Study concept and design: Ovbiagele, Reeves, Saposnik.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Ovbiagele, Saposnik.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Reeves, Nasiri.
Obtained funding: Ovbiagele, Reeves, Saposnik.
Administrative, technical, or material support: Ovbiagele, Reeves, Saposnik.
Study supervision: Ovbiagele, Reeves, Johnston, Bath, Saposnik.
Conflict of Interest Disclosures: None reported.
Funding/Support: Dr Ovbiagele is supported by Award U01 NS079179 from the NINDS. Dr Saposnik is supported by the Clinician-Scientist Award from the Heart and Stroke Foundation of Canada and the Canadian Institute for Health Research.
Role of the Sponsor: The funding agencies had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Group Information: The VISTA-Acute Collaboration Steering Committee members are K. R. Lees (Chair), Institutes of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, Scotland; A. Alexandrov, University of Alabama Hospital, Birmingham; P. M. Bath, Institute of Neuroscience, University of Nottingham, Nottingham, England; E. Bluhmki, Boehringer Ingelheim, Biberach, Baden-Württemberg, Germany; N. Bornstein, Stroke Unit, Department of Neurology, Tel Aviv University Medical Center, Tel Aviv, Israel; L. Claesson, AstraZeneca LLP, Södertälje, Sweden; S. M. Davis, Department of Neurology, Royal Melbourne Hospital, University of Melbourne, Melbourne, Victoria, Australia; G. Donnan, Department Neurology, University of Melbourne, Melbourne, Victoria, Australia; H. C. Diener, Department of Neurology, University of Duisburg-Essen, Germany; M. Fisher, Department of Neurology, University of Massachusetts Medical School, Worcester; B. Gregson, Department of Neurosurgery, Newcastle University, Newcastle General Hospital, Newcastle, England; J. Grotta, Department of Neurology, University of Texas, Houston Medical School, Houston; W. Hacke and M. G. Hennerici, Department of Neurology, University of Heidelberg, Heidelberg, Germany; M. Hommel, Joseph Fourier University, Grenoble, France; M. Kaste, Department of Neurology, Helsinki University Central Hospital, University of Helsinki, Helsinki, Finland; P. Lyden, Cedars-Sinai Medical Center, Los Angeles, California; J. Marler, US Food and Drug Administration, Silver Spring, Maryland; K. Muir, Division of Clinical Neurosciences, University of Glasgow, Glasgow, Scotland; R. Sacco, Miller School of Medicine, University of Miami, Miami, Florida; A. Shuaib, Stroke Program, University of Alberta, Edmonton, Alberta, Canada; P. Teal, University of British Columbia, Vancouver, British Columbia, Canada; N. G. Wahlgren, Karolinska Hospital, Stockholm, Sweden; S. Warach, Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Austin; and C. Weimar, Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Germany.